Clinical Trial

Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study.

Study acronym: LIPINFAT
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to evaluate whether the Oral Fat Loading Test (OFLT) determines a different response in terms of the quantity, quality, and kinetics of triglyceride-rich lipoproteins in subjects with T2D, prediabetics, and control subjects, and whether triglyceride-rich lipoproteins and inflammatory cytokines after OFLT are potential early biomarkers of the risk of progression to diabetes and the development of complications in a general practice setting. To address these questions, a hybrid cohort study was designed by identifying three groups of subjects: T2D and prediabetics (exposed and near-exposed) and control subjects (unexposed).
Trial Details
NCT Number NCT07602023
Lead Sponsor Angelina Passaro
Collaborators: University Hospital of Ferrara, S. Anna Hospital, Azienda USL Ferrara, Università degli Studi di Ferrara
Conditions Prediabetes / Type 2 Diabetes
Enrollment 150 participants
Start Date 2024-05-14
Primary Completion 2026-05-14 (estimated)
Study Completion 2028-05-14 (estimated)
Updated on ClinicalTrials.gov 2026-05-22